Genetic & Molecular Medicine

-- Test Associated with Changes in Treatment Management in 65% of Patients with Difficult-to-Diagnose Cancers -- REDWOOD CITY, Calif. -- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their...

Developing therapeutics using novel biology to selectively activate genes CAMBRIDGE, Mass. -- RaNA Therapeutics, Inc. today announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and...

Leading Research Institution Chooses Automation Solution to Meet New HHS Rules CHICAGO -- Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced that Cincinnati Children's Hospital Medical Center...

SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2011 following the close of market on Tuesday, January 31, 2012. On the same...

Cold adapted and heat-labile unique Enzymes that Improve Molecular Biology TROMSO, Norway -- ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. The Company...

MDx Customers Realize Average Cash Improvements of More Than 25 Percent, Bad Debt Reductions of 50 Percent SAN DIEGO -- XIFIN Inc., the company revolutionizing revenue cycle management for diagnostic service providers, announced...

Carlsbad-based Isis Pharmaceuticals Inc. said it has entered into agreement with biotechnology giant Biogen Idec of Weston, Mass., to develop and commercialize an investigational drug for a rare genetic disorder known as spinal...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/d990a7/product_profiles) has announced the addition of the "Product Profiles: Targeted Cancer Therapies - Trend towards personalized medicine will lead to market fragmentation" report to their offering. The targeted therapies...

New Patents Demonstrate Carestream's Investment, Commitment to Developing Innovative Technology ROCHESTER, N.Y. -- Carestream and its subsidiaries were awarded 47 patents in 2011 for innovations in its radiology imaging and healthcare IT, dental...

BioTrends Research Group, LLC has released findings from the LaunchTrends([R]): Xalkori report, which is tracking the launch of this new targeted therapy. The study finds that Pfizer's Xalkori (crizotinib), which is indicated for...

The Montreal Heart Institute will work with GnuBIO to develop a genetic sudden cardiac death screening panel in order to predict risk in patients CAMBRIDGE, Mass. -- GnuBIO, Inc. (GnuBIO), www.gnubio.com a pioneer...

Speed and Performance Enhancements Pave the Way to Future Clinical Use Company Also Announces Three-Fold Increase in MiSeq Throughput SAN FRANCISCO -- Illumina (Nasdaq:ILMN) today introduced the HiSeq[R] 2500, a next-generation sequencing system...

SANTA CLARA, Calif. & SEATTLE -- Agilent Technologies Inc. (NYSE: A) and Integrated Diagnostics today announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/3bae3b/muscular_dystrophy) has announced the addition of Global Markets Direct's new report "Muscular Dystrophy - Pipeline Review, H2 2011" to their offering. Global Markets Direct's, 'Muscular Dystrophy - Pipeline Review,...

Fifth Partnership Will Help Translate Cancer Genomic Science to Clinical Results CAMBRIDGE, Mass. -- Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genome analysis to routine clinical care, today announced...

Medical Diagnostics CEO Pascale Witz Addresses Conference PRINCETON, N.J. -- Pascale Witz, President and CEO, GE Healthcare, Medical Diagnostics discussed diagnostics as the future of personalized medicine at the 30th JP Morgan Healthcare...

- Partnership Includes US Profit Share and Co-Promotion Option for Epizyme - CAMBRIDGE, Mass. -- Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer patients, today announced...

Program Provides GenomeQuest Software, Services, and Expertise to Convert and Consolidate Sanger Gene Test Panels WESTBOROUGH, Mass. -- GenomeQuest Inc., a global provider of large-scale genomic software applications, announced today that it has...

San Diego-based Quidel Corp. said the Food and Drug Administration has cleared the company's first two molecular diagnostic tests for infectious diseases. One of the tests screens for a respiratory disease called human...